A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case report

The identification of NTRK fusions in tumours has become critically important due to the actionable events predictive of response to TRK inhibitor. It is not clear whether the NTRK breakpoint location is diffe...

Source: BMC Pulmonary Medicine - April 17, 2021 Category: Respiratory Medicine Authors: Lei Zhang, Huanhuan Liu, Ye Tian, Huina Wang and Xueying Yang Tags: Case report Source Type: research